Exscientia shares are trading higher after the company announced an AI drug discovery collaboration with Merck KGaA, Darmstadt, Germany.
Portfolio Pulse from Benzinga Newsdesk
Exscientia announced a collaboration with Merck KGaA, Darmstadt, Germany for AI drug discovery. This news has led to a rise in Exscientia's share prices.

September 20, 2023 | 12:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Exscientia's shares are trading higher after the announcement of a collaboration with Merck KGaA for AI drug discovery.
The announcement of the collaboration with Merck KGaA for AI drug discovery is a positive development for Exscientia. This partnership could potentially lead to new drug discoveries, which would be beneficial for the company. As a result, investors are reacting positively, leading to a rise in the company's share prices.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100